Year archive

LTR PHARMA LIMITED — 2024 filings

All 50 regulatory filings released by LTR PHARMA LIMITED (LTP) in 2024, sourced directly from the official regulator.

50 Filings

2024 Period

2024 filings (50)

Filing	Released	Lang
Response to ASX Query Letters 13 pages 1.6MB Regulatory Filings	2024-12-29	English
Agreement with Men's Health Pharmacy for SPONTAN access 2 pages 162.7KB Regulatory Filings	2024-12-18	English
Application for quotation of securities - LTP 6 pages 18.2KB Regulatory Filings	2024-12-16	English
Cleansing Notice 2 pages 107.6KB Regulatory Filings	2024-12-16	English
Early Launch of Online Mens Health Platform 2 pages 139.1KB Regulatory Filings	2024-12-11	English
Change of Company Secretary 1 page 82.8KB Regulatory Filings	2024-12-10	English
LTR Pharma Announces Successful A$25 million Placement 3 pages 164.2KB Regulatory Filings	2024-12-09	English
Proposed issue of securities - LTP 5 pages 18.1KB Regulatory Filings	2024-12-09	English
Investor Presentation 33 pages 3.2MB Regulatory Filings	2024-12-09	English
Notification regarding unquoted securities - LTP 7 pages 22.0KB Regulatory Filings	2024-12-08	English
Change of Director's Interest Notices 9 pages 401.4KB Regulatory Filings	2024-12-08	English
Trading Halt 2 pages 540.1KB Regulatory Filings	2024-12-05	English
Ord Minnett Biotechnology Conference Presentation 24 pages 2.1MB Regulatory Filings	2024-11-27	English
AGM Presentation 13 pages 1.7MB Regulatory Filings	2024-11-26	English
Results of Meeting 2 pages 95.5KB Regulatory Filings	2024-11-26	English
JV with Leading Men's Health Group for Online Platform 2 pages 162.5KB Regulatory Filings	2024-11-11	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 417.3KB Regulatory Filings	2024-10-27	English
Notice of Annual General Meeting/Proxy Form 24 pages 522.5KB Regulatory Filings	2024-10-27	English
Annual Report to shareholders 44 pages 3.5MB Regulatory Filings	2024-10-27	English
SPONTAN Final Study Results 3 pages 173.0KB Regulatory Filings	2024-10-13	English
Appendix 4E and Annual Financial Report 65 pages 2.8MB Regulatory Filings	2024-08-29	English
FY24 Results Announcement 3 pages 148.2KB Regulatory Filings	2024-08-29	English
Appendix 4G and Corporate Governance Statement 26 pages 612.2KB Regulatory Filings	2024-08-29	English
SPONTAN Prescribed to First Patient by Authorised Prescriber 2 pages 154.6KB Regulatory Filings	2024-08-15	English
LTP Secures Global CoDevelopment Agreement with Aptar Pharma 2 pages 137.9KB Regulatory Filings	2024-08-12	English
Mens Health Expert Prescribes SPONTAN 2 pages 165.6KB Regulatory Filings	2024-08-07	English
SPONTAN prescribed to First Patient Under TGA 2 pages 178.5KB Regulatory Filings	2024-08-04	English
Application for quotation of securities - LTP 6 pages 18.3KB Regulatory Filings	2024-07-30	English
Cleansing Notice 2 pages 83.8KB Regulatory Filings	2024-07-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 379.6KB Regulatory Filings	2024-07-28	English
LTR Pharma completes A$10.5 million placement 3 pages 148.2KB Regulatory Filings	2024-07-23	English
Proposed issue of securities - LTP 5 pages 17.7KB Regulatory Filings	2024-07-23	English
Investor Presentation 30 pages 2.8MB Regulatory Filings	2024-07-23	English
Investor Webinar 1 page 83.8KB Regulatory Filings	2024-07-23	English
Trading Halt 2 pages 175.3KB Regulatory Filings	2024-07-21	English
SPONTAN achieves positive clinical study results 4 pages 237.5KB Regulatory Filings	2024-06-06	English
Reinstatement to quotation 1 page 89.5KB Regulatory Filings	2024-06-06	English
Suspension from Quotation 2 pages 176.2KB Regulatory Filings	2024-06-05	English
Trading Halt 2 pages 207.2KB Regulatory Filings	2024-06-03	English
Response to ASX Price Query 4 pages 258.1KB Regulatory Filings	2024-05-21	English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 402.5KB Regulatory Filings	2024-04-28	English
Notification regarding unquoted securities - LTP 8 pages 27.3KB Regulatory Filings	2024-04-17	English
Final Patients dosed in SPONTAN pivotal study 2 pages 146.4KB Regulatory Filings	2024-03-24	English
First patients dosed in SPONTAN pivotal study 2 pages 164.9KB Regulatory Filings	2024-03-18	English
Investor Presentation 22 pages 1.9MB Regulatory Filings	2024-03-17	English
Appendix 4D and Half Yearly Report 23 pages 19.9MB Regulatory Filings	2024-02-27	English
Recruitment commences for SPONTAN Clinical Study 2 pages 148.0KB Regulatory Filings	2024-02-18	English
Notification regarding unquoted securities - LTP 6 pages 20.1KB Regulatory Filings	2024-02-15	English
SPONTAN Achieves Key Manufacturing Validation 2 pages 133.9KB Regulatory Filings	2024-02-05	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 444.5KB Regulatory Filings	2024-01-29	English